SGX942
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SGX942, covering 2017-07-31 to 2022-08-29. Get the full timeline:
Most recent: Clinical Trial Update: DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer [Phase 3]